2024 Rongxiang Xu Center Annual Conference at Harvard: Advancing Diabetic Limb Disease Treatment
The 2024 annual conference of the Rongxiang Xu Center for Regenerative Therapeutics at Harvard Medical School took place in Boston on November 7-8, focusing on breakthroughs in diabetic limb disease treatment. This event attracted global experts who gathered to explore challenges in diabetic limb management, innovative therapies, and advances in foot-preserving care within interdisciplinary teams.
Keynote Highlights Innovative Diabetic Limb Treatments
Dr. Marc Schermerhorn, Chief of Vascular Surgery at Harvard’s BIDMC, delivered the keynote, offering insights into ischemic limb disease, anticipated trends, and recent breakthroughs from the Xu Center’s research. His address set the tone for discussions on the center’s forward-thinking approach to diabetic limb disease.
Global Experts Share Success with Regenerative Techniques
Guest speakers, Dr. Mar Florentino from the Philippines and Dr. Edwin Widjaja from Indonesia, shared their extensive experience with regenerative medicine for diabetic foot conditions. They emphasized the unique benefits of this technique in improving patient outcomes.
Global Collaboration and Recognition at the Harvard Club
The event concluded with a reception at the Harvard Club, hosted by Dr. Aristidis Veves, Director of the Xu Center, with notable guests like Li Li, Chair of National Rongxiang Xu Foundation in America. Li commended the center’s achievements and emphasized the potential of ongoing research to benefit diabetic limb patients worldwide.
About MEBO
Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.
At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.
As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.
stay informed. connect with us.
